AI-generated summary
The authors review red and near-infrared light as a possible treatment for amyotrophic lateral sclerosis, a fatal neurodegenerative disease. They argue, based on its reported effects in other neurodegenerative diseases and its multi-modal action against ALS pathology, that it may be a valuable option, particularly if started early. The abstract describes this as a chapter exploring potential effectiveness rather than reporting a clinical study.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a narrative book chapter proposing a rationale and reports no patient data or measured outcomes in ALS.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Near-infrared, Neuroinflammation, Dementia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.